
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Travere typically reports after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-08-04 | +$1.04 (+1.89%) | $2.45 (4.46%) | +$6.74 (+12.03%) | $5.24 (9.35%) |
| 2026-05-04 | +$0.79 (+1.79%) | $1.67 (3.79%) | -$0.11 (-0.24%) | $5.55 (12.36%) |
| 2026-02-19 | +$1.43 (+5.13%) | $1.47 (5.27%) | +$1.09 (+3.72%) | $2.97 (10.14%) |
| 2025-10-30 | -$0.33 (-1.10%) | $0.91 (3.04%) | +$5.51 (+18.58%) | $3.23 (10.89%) |
| 2025-08-06 | +$0.56 (+3.36%) | $1.09 (6.50%) | -$0.33 (-1.91%) | $1.85 (10.76%) |
| 2025-05-01 | -$0.05 (-0.24%) | $0.69 (3.32%) | +$0.39 (+1.88%) | $1.56 (7.51%) |
| 2025-02-20 | +$0.25 (+1.07%) | $0.55 (2.36%) | -$1.60 (-6.79%) | $1.90 (8.06%) |
| 2024-10-31 | -$0.25 (-1.44%) | $1.51 (8.50%) | +$0.07 (+0.40%) | $1.16 (6.66%) |
| Avg Abs Move | 2.00% | 4.65% | 5.69% | 9.47% |
Historical price action around earnings shows substantial volatility, with the stock averaging a 5.69% absolute move on Day +1 and a 9.47% trading range. The most dramatic reaction came after Q3 2025 results, when the stock surged 18.58% on Day +1 following the massive earnings beat. More recently, Q2 2026's disappointing results drove a 12.03% Day +1 move with a 9.35% range, demonstrating the market's sensitivity to bottom-line execution. The Day 0 moves average 2.00%, indicating modest anticipatory positioning, while the Day +1 average of 5.69% suggests investors wait for actual results before making significant adjustments. Given the current setup—with two consecutive quarters of large misses and heightened focus on the profitability trajectory—investors should prepare for potential volatility in the 5-10% range following this release.
| Metric | Value |
|---|---|
| Expiration Date | 11/20/26 (DTE 21) |
| Expected Move | $5.00 (9.92%) |
| Expected Range | $45.39 to $55.39 |
| Implied Volatility | 60.16% |
The options market is pricing a 9.92% expected move through the November 20 expiration, significantly higher than the 5.69% average Day +1 move observed historically. This elevated implied volatility suggests options traders are anticipating a larger-than-typical reaction, likely reflecting uncertainty around the profitability trajectory and the impact of recent ASN conference data on forward guidance.
Analysts maintain a Strong Buy consensus on Travere, with 14 Strong Buy ratings, 0 Moderate Buys, 1 Hold, 0 Moderate Sells, and 1 Strong Sell among 16 analysts covering the stock. The average price target of $75.21 implies 49.3% upside from the current price of $50.39, with estimates ranging from a low of $62.00 to a high of $90.00.
However, sentiment has deteriorated over the past month. The analyst consensus has weakened from an average recommendation of 4.75 one month ago to 4.63 currently, with one analyst downgrading from Hold to Strong Sell. This shift reflects growing caution about near-term profitability challenges despite the bullish long-term thesis on Filspari's commercial potential.
The wide range in price targets—from $62.00 to $90.00—underscores divergent views on execution risk versus the franchise's durability. Bulls point to the expanded FSGS indication, extended patent protection through 2037, and strong clinical data as drivers of sustained revenue growth. Bears focus on the company's inability to translate top-line momentum into bottom-line results, with two consecutive quarters of significant earnings misses raising questions about the path to profitability. Despite the recent sentiment deterioration, the overwhelmingly positive rating distribution and substantial implied upside suggest most analysts view current weakness as a buying opportunity ahead of what they expect will be improving fundamentals.
The Barchart Technical Opinion currently shows a Sell signal at 8%, unchanged from last week but representing a significant deterioration from the Buy signal at 56% registered one month ago. This sharp reversal reflects mounting technical pressure as the stock has pulled back from recent highs.
Timeframe Analysis:
Trend Characteristics: The signal strength is at Minimum levels and the direction is Weakening, indicating a fragile technical environment with deteriorating momentum heading into the earnings release.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $50.53 | 50-Day MA | $59.06 |
| 10-Day MA | $51.05 | 100-Day MA | $58.29 |
| 20-Day MA | $52.06 | 200-Day MA | $46.62 |
At $50.39, TVTX is trading below its 5-day ($50.53), 10-day ($51.05), 20-day ($52.06), 50-day ($59.06), and 100-day ($58.29) moving averages, but remains above the critical 200-day moving average at $46.62. This configuration shows the stock in a clear downtrend across all short- and intermediate-term timeframes, with the 200-day average serving as the last line of technical support. The stock has declined approximately 15% from its 52-week high of $68.73 reached in September, and the clustering of moving averages above current levels creates significant overhead resistance. The RSI reading of 35.95 suggests the stock is approaching oversold territory but has not yet reached extreme levels. The overall technical setup is cautionary heading into earnings, with the stock vulnerable to further downside if results disappoint, though the proximity to the 200-day moving average could provide a floor for buyers if the company delivers positive surprises on revenue growth or profitability guidance.